Security key
G50871105
Jazz Pharmaceuticals plc - Common Stock (JAZZ)
CUSIP: G50871105
Q1 2020 13F Holders as of 31 Mar 2020
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 49,800,360
- Total 13F value
- $4,968,187,513
- Share change
- -2,054,861
- Put/Call ratio
- 157%
- SEC-reported price per share
- $99.74
- Number of holders
- 397
- Value change
- -$262,951,825
- Number of buys
- 168
- Number of sells
- 250
- Shares outstanding
- 61,577,817
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2020
Institutions
397
Top holders
10
JAZZ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Jazz Pharmaceuticals plc SEC filings
Jazz Pharmaceuticals plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP G50871105
Recent filing periods:
Ownership snapshot
Top reported holders of JAZZ - Jazz Pharmaceuticals plc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2019
13F
Lead comparable stake: 8.2%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 8.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
VANGUARD GROUP INC
8.2%
BlackRock Finance, Inc.
6.8%
RENAISSANCE TECHNOLOGIES LLC
5.8%
AQR CAPITAL MANAGEMENT LLC
3.2%
JPMORGAN CHASE & CO
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
8.2%
|
$752,553,000
5,041,218 shares
|
— | 31 Dec 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
6.8%
|
$621,533,000
4,163,547 shares
|
— | 31 Dec 2019 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
5.8%
|
$529,850,000
3,549,371 shares
|
— | 31 Dec 2019 |
| AQR CAPITAL MANAGEMENT LLC |
13F
Company
|
3.2%
|
$292,598,000
1,966,252 shares
|
— | 31 Dec 2019 |
| JPMORGAN CHASE & CO |
13F
Company
|
3.1%
|
$285,156,000
1,910,204 shares
|
— | 31 Dec 2019 |
| LSV ASSET MANAGEMENT |
13F
Company
|
3%
|
$278,544,000
1,865,919 shares
|
— | 31 Dec 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
397
Shares
49,800,360
Rows available
397
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
436
Q1 2020 holders
397
Holder diff
-39
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 value | Q1 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend